Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04693247
Other study ID # EYEQUE - 004
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 28, 2020
Est. completion date June 21, 2023

Study information

Verified date August 2022
Source EyeQue Corp.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is exploratory and examines whether the best-corrected visual acuities (BCVA's) from trial frames created with the refraction results obtained from a novel handheld optical device yields results similar to the ophthalmic refraction obtained from an autorefractor in healthy volunteers age stratum of 18 through 65 years.


Description:

This study is exploratory and examines whether the best-corrected visual acuities (BCVA's) from trial frames created with the refraction results obtained from a novel handheld optical device yields results similar to the ophthalmic refraction obtained from an autorefractor in healthy volunteers age stratum of 18 through 65 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 35
Est. completion date June 21, 2023
Est. primary completion date June 21, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Male or Female - Ages =>18 y.o. and =<65 y.o. - Binocular vision - Willing and able to give informed consent and follow all study procedures and requirements - Fluent in English Exclusion Criteria: - Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19. - Has traveled outside the country within the last 4 weeks. - At the discretion of the investigator: Age strata has achieved minimum evaluable population. - Spherical correction > +8 or < -10 - Using anticholinergic medications (including first-generation antihistamines) or other medications known to affect visual acuity within the greater of 3 days or 5 half-lives prior to enrolling in this study - Using an investigational drug or approved therapy for investigational use within the greater of 3 days or 5 half-lives prior to enrolling in this study - Has initiated any new medication in the past 2 weeks that, in the best medical judgment of the investigator, would impact their participation in the study or ability to use the EyeQue EQ103 device - Any self-reported mental illness or condition, including but not limited to: claustrophobia, fear of simulators, nyctophobia. - Any self-reported neurological diseases, including but not limited to: epilepsy, Alzheimer's, nystagmus Per subject self-reporting: eye disease, including but not limited to: - Glaucoma - Cataracts - Macular degeneration - Eye infection (by self-report or observation) - Keratoconus - Diabetic neuropathy/retinopathy - Cytomegalovirus retinitis - Color blindness (any color deficiency) - Diabetic macular edema - Amblyopia - Chronic or acute uveitis - Strabismus - Astigmatism > 3 diopters - Macular hole Subjects that: - Lack physical dexterity to properly operate the EyeQue device. - Lack the ability to follow instruction - Lack a command of the English language - Lack binocular vision - Are colorblind - Had eye surgery within the last 12 months (including Lasik)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EQ103
Refraction device

Locations

Country Name City State
United States EyeQue Newark California

Sponsors (1)

Lead Sponsor Collaborator
EyeQue Corp.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Best corrected visual acuity (BCVA) for both eyes EQ103 vs Autorefractor for all participants Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart) for each eye from (pooled) trial frames created with the refraction values compared with those of an autorefractor analyzed with all age groups. Day 1
Secondary Best corrected visual acuity (BCVA) for both eyes EQ103 vs Autorefractor examining age groupings Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart for each eye (pooled) from trial frames created with the refraction values compared with those of an autorefractor analyzed within the following age strata.
o Age Groups: 18 - 29, 30 - 44, 45 - 65
Day 1
Secondary Best corrected visual acuity (BCVA) for worse eye: EQ103 vs Autorefractor for all subjects and age groupings Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart for worse eye from trial frames created with the refraction values compared with those of an autorefractor analyzed within the following age strata.
o Age Groups: All, 18 - 29, 30 - 44, 45 - 65
Day 1
See also
  Status Clinical Trial Phase
Completed NCT04532099 - Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses N/A
Completed NCT05039112 - Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses N/A
Completed NCT03670303 - Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan N/A
Completed NCT02255474 - Bifocal Lenses In Nearsighted Kids N/A
Not yet recruiting NCT03222661 - Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction N/A
Completed NCT04055519 - Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens N/A
Recruiting NCT05049070 - Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction N/A
Completed NCT04527978 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1 N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Not yet recruiting NCT04077086 - Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities N/A
Withdrawn NCT04352868 - Customizing Myopia Control With Multifocal Toric Contact Lens N/A
Completed NCT04528017 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2 N/A
Recruiting NCT04338880 - Academic Performance and Refractive Error
Recruiting NCT04545073 - Outcomes of a Trifocal IOL in Post-refractive Patients
Enrolling by invitation NCT05992675 - Air Optix® Night and Day® Aqua Continuous Wear
Enrolling by invitation NCT05976750 - Air Optix® Night and Day® Aqua Daily Wear
Recruiting NCT06065631 - Seeing to Learn in Sierra Leone N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A
Not yet recruiting NCT06044688 - EyeQue VisionCheck 510(k) Clinical Trial N/A